Invesco Ltd. Bio Xcel Therapeutics, Inc. Transaction History

Invesco Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.95 - $4.04 $9,145 - $18,947	4,690 Added 33.14%	18,841 $53,000
Q4 2023 Feb 12, 2024	BUY	$2.32 - $5.51 $32,830 - $77,972	14,151 New	14,151 $41,000
Q4 2021 Feb 14, 2022	SELL	$20.12 - $35.09 $149,028 - $259,911	-7,407 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $176,582 - $237,246	7,407 New	7,407 $226,000
Q3 2020 Nov 16, 2020	SELL	$37.44 - $64.63 $4.13 Million - $7.13 Million	-110,370 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $1.94 Million - $6.48 Million	110,370 New	110,370 $5.85 Million

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $12.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.